期刊文献+

阿达木单抗抗原结合片段在大肠杆菌中的共分泌表达和纯化 被引量:2

Co-Expression of Adalimumab Antigene-Binding Fragments in E. coli and Purification
原文传递
导出
摘要 构建阿达木单抗抗原结合片段(Fragment antigen binding,Fab)表达载体,使其在大肠杆菌内高效共分泌表达,周质空间中获得具有活性的目的蛋白。将带有信号肽的Fab片段重链与轻链克隆于带有双启动子的pETDuet-1载体内,BL21(DE3)Star宿主菌内利用IPTG低温诱导双基因共分泌表达,选用"渗透压冲击法"提取周质蛋白,色谱柱纯化,Western blot分析纯化结果,与纯化的人肿瘤坏死因子(TNF-α)相互作用进行活性分析。SDS-PAGE与Western blot分析在细胞周质中同时存在重链和轻链,大小与预期相符,ELISA试验显示Fab片段与TNF-α结合。结论:得到有活性的人源的阿达木单抗的Fab的可溶性表达产物,为进一步对其进行结构与功能的研究奠定了基础。 To obtain the active antigen-binding fragment( Fab) of Adalimumab from E. coli by constructing a secretory expression system using'double gene'expression vector,the cDNA of light chain and heavy chain of Adalimumab fab along with signal peptide PelB and OmpA respectively,were cloned into vector pETDuet-1. The resulting plasmids was transformed in BL21( DE3) Star,induced by IPTG at low temperature. The active Adalimumab Fab protein was obtained through the periplasmic extraction,affinity purification,ion exchange and size exclusion chromatography. The Adalimumab Fab protein was analyzed by SDS-PAGE,Western blot and ELISA. SDS-PAGE and Western Blot analysis showed that both heavy chain and light chain were successfully translocated into the periplasm of E. coli and the formed heterologous dimer. The purified Adalimumab Fab protein from multipul purification steps could interact with its antigen TNF-α. Active Adalimumab Fab protein was successfully obtained from E. coli periplasm using'double gene'expression vector,which provided an economic and convenient method for the study on biological function and industry production of Adalimumab Fab.
出处 《药物生物技术》 CAS 2014年第3期204-208,共5页 Pharmaceutical Biotechnology
关键词 阿达木单抗 抗原结合片段 共分泌表达 周质蛋白提取 色谱柱分离纯化 活性分析 Adalimumab,Fragment antigen binding,Co-expression,Periplasmic extraction,Chromatography,Activity analysis
  • 相关文献

参考文献5

  • 1Jean–Frédéric Colombel,William J. Sandborn,Paul Rutgeerts,Robert Enns,Stephen B. Hanauer,Remo Panaccione,Stefan Schreiber,Dan Byczkowski,Ju Li,Jeffrey D. Kent,Paul F. Pollack.<ce:link locator="fx1"/> Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial[J].Gastroenterology.2007(1)
  • 2Veronica Quintero-Hernández,Victor R. Juárez-González,Mauricio Ortíz-León,Rosalba Sánchez,Lourival D. Possani,Baltazar Becerril.The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies[J].Molecular Immunology.2006(6)
  • 3Yu-Cheng Chen,Li-An Chen,Shu-Jen Chen,Ming-Chung Chang,Teh-Liang Chen.A modified osmotic shock for periplasmic release of a recombinant creatinase from Escherichia coli[J].Biochemical Engineering Journal.2004(3)
  • 4Michael E.Weinblatt,Edward C.Keystone,Daniel E.Furst,Larry W.Moreland,Michael H.Weisman,Charles A.Birbara,Leah A.Teoh,Steven A.Fischkoff,Elliot K.Chartash.Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial[J].Arthritis & Rheumatism.2003(1)
  • 5Fran?ois Baneyx.Recombinant protein expression in Escherichia coli[J].Current Opinion in Biotechnology.1999(5)

共引文献4

同被引文献30

  • 1马泓冰,庄羽美,徐颖,郁健锋,刘琳,李文香,张学光.阳离子交换一步层析法纯化抗gp130单克隆抗体[J].细胞与分子免疫学杂志,2005,21(3):337-339. 被引量:2
  • 2周华蕾,吕茂民,王娜,刘子,章金刚.应用A蛋白亲和层析法纯化单克隆抗体[J].生物技术通报,2005,21(5):72-74. 被引量:18
  • 3马泓冰,孙中文,徐颖,李文香,陶然,陈洁,张学光.两步串联层析法纯化鼠抗人CD28单克隆抗体2F5[J].细胞与分子免疫学杂志,2007,23(2):152-154. 被引量:5
  • 4Tsuji S, Higashiyama M, Inaoka M, et al. Effects of adalimumabtherapy on musculoskeletal manifestations and health-related quality of life in patients with active psoriatic arthritis [ J ] . Modern Rheumatology, 2013, 23 ( 3 ) : 529-537.
  • 5Gagnon P. Technology trends in antibody purification [ J ] . Journal of Chromatography A, 2012, 1221 : 57-70.
  • 6Ayyar BV, Arora S, Murphy C, et al. Affinity chromatography as a tool for antibody purification [ J ] . Methods, 2012, 56 ( 2 ) : 116- 129.
  • 7Hober S, Nord K, Linhuh M. Protein A chromatography for antibody purification [J] . Journal of Chromatography, 2007, 848 ( 1 ) : 40- 47.
  • 8Liu Q. Fully human antibody to human TNF-ct, molecular evolution and use thereof : US, 8354108 [ P ] . 2013-01-15.
  • 9Lathem WW, Price PA, Miller VL, et al. A plasminogen-activating protease specifically controls the development of primary pneumonic plague [J] . Science, 2007, 315 ( 5811 ) : 509-513.
  • 10Li B, Guo Y, Guo Z, et al. Serologic sm'vey of the sentinel animalsfor plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray [ J ] . Am J Trop Med Hyg, 2008, 79 ( 5 ) : 799-802.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部